A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months with additional 6 months follow-up.
Epistemonikos ID: 0468e655524574e2084992dd9c68a19e555b015e
First added on: May 15, 2024